Atlas Trials

Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients

Clinical trial NCT04494204 · COMPLETED

Trial details

NCT number
NCT04494204
Sponsor
PUNEET MITTAL
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Treatment of Covid-19 Virus Infection
Start date
2020-08-07
Primary completion
2020-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.